Target intelligence / Profile preview

Viral antigen from Measles virus, Mumps virus, Rubella virus, or Varicella-zoster virus

Molecular classification
Other (virally encoded protein antigens; not classified as receptor, enzyme, transporter, etc.)
01

Overview

Viral antigens from Measles virus, Mumps virus, Rubella virus, and Varicella-zoster virus are immunogenic proteins present in these four distinct viruses. They are the targets recognized by the host immune system during infection and after vaccination, leading to the production of specific antibodies and cellular immune responses. Measurement of immunity to these viral infections generally relies on the detection of IgG antibodies directed against these antigens. These antigens form the basis of live attenuated vaccines (MMR and MMRV), which provide long-lasting protection against the respective diseases. This entry improperly combines four unrelated viral antigens, which should each be listed separately for molecular specificity[1][5][9].

Other names
Measles antigenMumps antigenRubella antigenVaricella-zoster antigenMMRV antigens
02

Mechanism of action

Induction of immune response (vaccines containing these antigens provoke the immune system to produce virus-specific antibodies and memory cells, conferring protection against future infection)

03

Biological functions

Immune response (the antigens are recognized by immune cells and stimulate protective antibody and T cell responses)
04

Disease associations

Infection (they are central in infections with their respective viruses: measles, mumps, rubella, varicella/chickenpox)
05

Safety considerations

Vaccine-related concerns such as allergic reactions, febrile seizures, and rare risk of immunocompromised patients developing complications from live vaccines
06

Interacting drugs

Measles, mumps, rubella, and varicella virus vaccine (live)
07

Biomarkers

IgG-class antibody against each viral antigen (used for determining immune status following vaccination or natural infection)

Beyond the preview

Go deeper on Viral antigen from Measles virus, Mumps virus, Rubella virus, or Varicella-zoster virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral antigen from Measles virus, Mumps virus, Rubella virus, or Varicella-zoster virus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call